Cargando…
Toward quantitative neuroimaging biomarkers for Friedreich's ataxia at 7 Tesla: Susceptibility mapping, diffusion imaging, R (2) and R (1) relaxometry
Friedreich's ataxia (FRDA) is a rare genetic disorder leading to degenerative processes. So far, no effective treatment has been found. Therefore, it is important to assist the development of medication with imaging biomarkers reflecting disease status and progress. Ten FRDA patients (mean age...
Autores principales: | Straub, Sina, Mangesius, Stephanie, Emmerich, Julian, Indelicato, Elisabetta, Nachbauer, Wolfgang, Degenhardt, Katja S., Ladd, Mark E., Boesch, Sylvia, Gizewski, Elke R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590084/ https://www.ncbi.nlm.nih.gov/pubmed/32731306 http://dx.doi.org/10.1002/jnr.24701 |
Ejemplares similares
-
Autonomic function testing in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2018) -
Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
por: Boesch, Sylvia, et al.
Publicado: (2019) -
Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023) -
Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023) -
Body Mass Index and Height in Friedreich Ataxia: What Do We Know?
por: Boesch, Sylvia M., et al.
Publicado: (2021)